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Abstract 
Data science extracts new knowledge from high dimensional datasets through 
computer science and statistics. Mental health research, diagnosis and treatment 
can benefit from data science using consented cohort studies, genomics, routine 
healthcare and administrative data. The UK is well placed to trial these 
approaches through well annotated and NHS-linked data science projects, such 
as UK Biobank, Generation Scotland and the Clinical Record Interactive Search 
(CRIS) programme. Data science has great potential as a low cost, high return 
catalyst for how mental health problems may be better recognised, understood, 
supported and outcomes improved. Lessons learnt from such studies have the 
potential for global reach in terms of both their output and impact. 
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WHAT IS DATA SCIENCE? 
Data science is the extraction of knowledge from high-volume data, using skills 
in computing science, statistics and the specialist domain knowledge of experts1. 
Data science pervades global business and modern living and can partner 
technical revolutions, such as medical genomics and imaging, to revolutionise 
the monitoring, diagnosis, treatment and prevention of disease. These ideals are 
implicit in ‘stratified medicine’ and ‘precision medicine’. The case for data science 
is often made for cancer, heart and infectious diseases. Here we argue for the 
enormous potential for data science to transform mental health research and 
clinical practice worldwide. International collaboration will be necessary for 
maximum reach and impact. We review the available resources, barriers and 
opportunities from a UK perspective before setting out how the full potential of 
data science could be realised on a global scale. 
 
Figure 1: What is data science? 
 
Insert Figure 1 here 
 
WHY MENTAL HEALTH AND WHY NOW? 
Mental disorders are arguably the greatest ‘hidden’ burden of ill health, with 
substantial long-term impacts on individuals, carers and society2. People with 
these conditions are often socially excluded3 and less likely to participate in 
research studies or remain in follow up4-6. Complexities around defining 
diagnoses present particular challenges for mental health research. Richly 
annotated, longitudinal datasets matched to data science analytics offer an 
unprecedented opportunity for more robust diagnostics, and also the prediction 
of outcome, treatment response, and patient preferences to inform 
interventions7. It may also provide more effective targeting of recruitment to 
observational and interventional studies. Such data are large in size and 
dimensions and require the application of advanced analytics, such as machine 
learning, where more conventional techniques are less computationally 
tractable.  
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A key issue in data science is the description of data types that are the most 
informative, readily available and efficiently captured. Generic data types include 
electronic health and prescribing records, education, welfare, socio-
demographic, laboratory and real world monitoring through wearable devices 
and environmental sensors. More specific data might include genomic data, in 
vivo brain imaging and cognitive traits. Important challenges include 
shortcomings in dataset completeness and linkage potential, as well as 
acceptability to patients and the wider public, given the perceived sensitivity of 
mental health data. It is also important to consider the types of information that 
can create new ways of classifying mental health and illness, and be universally 
applied beyond the ‘perfect world’ discovery setting. 
 
WHAT UK RESOURCES MIGHT HELP PIONEER THIS APPROACH? 
 
1. Population cohorts 
There are several UK population cohorts with enhanced clinical, biological and 
social datasets linked to routinely collected electronic data. We provide details of 
UK Biobank (www.ukbiobank.ac.uk) here. 
 
UK Biobank  
UK Biobank is a cohort study of 0.5 Million individuals aged between 37 and 73 
years recruited between 2006 and 2010. Participants completed a touch-screen 
questionnaire, underwent an interview, and participated in several assessments 
including measures of depressive symptoms, distress, cognition and alcohol and 
cigarette use. In addition, linkages have been made to National Health Service 
(NHS) healthcare episode data, and a number of biological measures have been 
taken, including DNA for whole-genome genotyping. An initial pilot medical 
imaging study includes unprocessed brain structure, function and connectivity 
data in over 5,000 participants, which is in the process of being extended to 
100,000 individuals. Further longitudinal and outcome assessments include 
repeat cognitive testing and actigraphy. Lifetime history of mental illness will be 
assessed in greater depth with a web-based questionnaire. UK Biobank thus 
brings unprecedented deep and broad phenotyping to mental health research8.  
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There are several other UK population cohorts with deeply-phenotyped 
participants and the potential for record linkage to routine healthcare and 
administrative data. Notable examples include The ‘Generation Scotland: 
Scottish Family Health Study’ (GS:SFHS)9,10, a family and population based 
study located in Scotland with near complete record linkage and the Avon 
Longitudinal Study of Parents and Children11, a UK-based cohort study with data 
available from before birth to more than 20 years follow up. Further information 
on these and other studies is provided in the online appendix. 
 
2. Domain specific cohorts linked to routinely collected data  
In contrast to population based research cohorts, several UK resources are 
focused on Mental Health and routinely collected clinical data from the NHS, the 
UK’s comprehensive healthcare provider. These data may be more 
representative of the general population and provide a framework for 
implementation. 
  
The The National Centre for Mental Health and SAIL Databank 
The National Centre for Mental Health (NCMH) was established in Wales in 2011 
and partnered to the MRC Centre for Neuropsychiatric Genetic and Genomics. 
The NCMH recruits participants with mental disorders to the NCMH cohort, 
currently at over 6000 individuals, who are willing to participate in research and 
be recontacted.  Clinical data (e.g. demographic, routine secondary care, 
enhanced clinical, neuropsychological, imaging) and biological samples are 
collected creating a platform and infrastructure for mental health research into 
the causes and treatment of mental illness and learning disability 
(www.ncmh.info).  In 2015 the Farr Institute partnered with the NCMH allowing 
for linkage of the cohort to routine data nested within prevalent diagnostic 
electronic cohorts within the Secure Anonymised Information Linkage (SAIL) 
databank (www.saildatabank.com)12,13. The SAIL Databank is a whole population 
based research data repository holding over 2Bn anonymised health records, 
from ~3.5M patients, from primary care, hospitals, child health, education, 
cause-specific mortality, deprivation and urbanicity. Participants can be tracked 
across health and social care settings, whilst protecting privacy in accordance 
with relevant legislation using a split file approach12,13. This is the first time 
genomic data has been linked to the SAIL databank14 allowing researchers to 
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address questions on the impact of genetic, environmental and health factors 
including modifiable lifestyle factors on clinically important outcomes.   
 
3. Electronic health record derived cohorts and the Farr Institute 
The increasing use of electronic health records is creating databases unparalleled 
both in sample size and in the depth of information contained. The use of these 
data for research is encouraged by policy15,16 and subject to necessary technical 
and ethical considerations17-19.  
 
An important distinction is made between structured information and 
unstructured text – the former being simpler to analyse, albeit that clinical 
uncertainties are often poorly coded20-23. Here, text mining may be employed 
alongside structured information to better define groups24,25. Structured 
information on patients requiring specialist care has been collected 
systematically by the NHS since 1981 through Hospital Episode Statistics in 
England, the Scottish Morbidity Record and Patient Episode Data for Wales. 
These are available to researchers as linked-data and are published in open-
access aggregated form26,27, along with primary care data28,1. Despite concerns 
about the speed and accuracy of these electronic data29,30, these resources may 
prove valuable for measuring real-world outcomes and assessing their mediators 
and predictors. 
 
In 2013 electronic medical record linkage was given further impetus by the 
founding of the UK Farr Institute for Health Informatics Research (see online 
appendix). It has the aim of harnessing health data for patient and pubic benefit 
by facilitating the safe and secure use of electronic patient records and other 
population based data sets.  
 
The Clinical Record Interactive Search (CRIS) application 
The CRIS application was developed at the South London and Maudsley NHS 
Foundation Trust in 2007 as a means of rendering the large volumes electronic 
mental health record data available for research31,32. CRIS accesses mental 
health case records from around 260,000 patients within a south London 
geographic catchment of approximately 1.2m residents; replications of CRIS 
have recently become operational elsewhere in London, Oxford and Cambridge. 
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Key to the development include data structuring and de-identification pipelines 
and also a wider data security and governance model which has been patient-led 
from the outset33. Research applications have included searches to help identify 
and characterise rare scenarios for further investigation34,35, and data linkage 
projects to characterise physical health outcomes36,37. Recent enhancements 
include the development of natural language processing applications to derive 
structured information from the text fields present in the electronic mental 
health record. These include recorded diagnoses, cognitive test scores, 
pharmacotherapy and symptom profiles38-42.  
 
The Child Outcomes Research Consortium approach is also a flagship electronic 
record UK project and is based around the outcomes of children and adolescents 
seen in specialist mental health services43. Further details are provided in the 
online appendix.  
 
Linkage to ‘real-time’ health data and wearable devices 
Companies such as Apple (Healthkit and Researchkit) and Google (Alphabet) are 
developing health based applications and wearable devices, as part of a wider 
array of environmental sensors, ‘The Internet of Things’, and health application 
developer toolkits. The potential to capture new sources of relevant ‘real-time’ 
and longitudinal health data (e.g. mood, diet, activity and sleep patterns), 
matched to physiological measures (e.g. of heart rate, blood glucose, cortisol) is 
potentially transformative and pervasive at low cost and independent of 
conventional healthcare provision.  A good, early example of such an initiative in 
psychiatry is Truecolours (https://oxfordhealth.truecolours.nhs.uk/www/en/), a platform 
developed to capture continuous patient-generated data with the required 
usability and acceptability to permit reliable longitudinal follow-up. It is also 
notable that this technology is currently being piloted as a supplement to routine 
healthcare.  
 
PUBLIC TRUST AND CLINICAL GOVERNANCE 
Whilst UK data science resources represent major opportunities for research and 
health service improvement, they demand public support, public trust and 
transparent governance arrangements. The MRC Farr Institute, the European 
Data in Health Research Alliance (datasaveslives.eu) and Patients4Data 
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(patients4data.co.uk) are all promoting the importance of data sharing for 
research and healthcare impact whilst acknowledging the potential risks of 
inaccurately recorded information and data breaches.  
 
Attitudes research suggests that mental health data are among the most 
personal and sensitive44,45. There are diverse reasons why people might be 
reluctant or unwilling to consent to the use of their data for mental health 
research46,47. Studies indicate, encouragingly, that a majority of mental health 
service users agree to the use of their health records for research – particularly 
when efforts to engage in on-going communication about their use and potential 
benefits are made32,48. It is important to reflect how cancer research has largely 
dispelled the past stigma of a cancer diagnosis: can modern day research, 
driven by data science, do the same for mental health? We think so, by 
reframing and redefining the causes and by reshaping and revitalising effective 
interventions.   
 
Safe and transparent models of governance for re-use of mental health data are 
essential for maintaining public trust. Systems have been developed that protect 
privacy and, in future, innovations such as dynamic models of consent49 may 
also allow the public further control over their data. The recently established Farr 
Institute (see appendix) includes a programme of public engagement with a 
focus on the safe and transparent use of patient and research data. 
 
The ‘Scottish Model’ 
The ‘Scottish Model’ is a useful illustrative example of how data science and 
record linkage can be conducted at scale and in a trusted environment. Like 
many Scandinavian countries, Scotland hosts excellent administrative and 
healthcare data resources. The NHS Community Health Index (CHI) - a unique 
personal identifier for 99% of the population, has greatly enabled 
pseudonymised linkage between health and administrative data (Figure 2). 
 
Figure 2. National level data resources in Scotland 
 
Insert Figure 2 here 
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Arguably, the other key to unlocking the benefits of routinely collected data in 
Scotland has been the presence of good research governance procedures and 
proactive engagement with the public to drive forward health informatics 
research. Public input into reviewing grant applications is standard practice, and 
includes providing later lay research summaries and wider dissemination in 
addition to public consultation and outreach. Consultation work suggests that 
the public supports the use of administrative and health data in research, 
provided there is adequate data security and access is limited to personnel 
conducting research for public benefit. The public appears more supportive of 
academic and clinical research than work conducted by commercial 
organisations44,50.  
 
All data outputs are scrutinised to ensure they do not identify individuals or 
breach privacy before being released. Open access summaries are published 
online as a condition of all research. Support to researchers throughout this 
process is provided by an eData Research and Innovation Service51. The key 
elements of the Scottish model are illustrated within Figure 2 (adapted from a 
previous publication51). 
 
 
TRAINING, RESOURCE AND CAPACITY IMPLICATIONS 
The availability and development of excellent resources for data science 
alongside robust governance procedures are necessary prerequisites for good 
data science.  We would argue that there are also specific technological and 
skills challenges to be overcome and that fulfilling the promise of data science 
will involve international collaboration spanning high and low income countries. 
 
1. Technological resource 
The capacity of data storage and access, and the personnel to collect and 
analyse data are rate-limiting steps in the ongoing development of data science. 
Routinely-collected ‘administrative’ and health data tend to be centrally financed 
by government but have limited phenotypic coverage and have, until recently, 
been used mainly for planning. More detailed phenotyping is possible in routine 
clinical data, such as CRIS in London and PsyCIS in Glasgow52, and large scale 
genetic, ‘-omics’ and neuroimaging studies generate huge volumes of data that 
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pose tractable data storage issues. The combination of these datasets is very 
challenging and requires data harmonisation and for compatibility issues to be 
addressed.  
 
Databases need to gather and hold data, and enable users to search for and 
access data of interest to them. Data sharing agreements and how to facilitate 
collaboration and innovation are key issues for data scientists. In practice, data 
generation projects are deciding on a case by case basis what they they will 
offer to centralised depositories without offering a coordinated solution for how 
that data will be linked to other sources. Centralised databases can make 
themselves more attractive to data depositors by offering managed data access 
and trusted analysis environments. The Global Alliance for Genomics and Health 
(https://genomicsandhealth.org) is an international example that brings 
together different health sectors and regions worldwide, to catalyse the sharing 
of methods to harmonise data approaches across diverse datasets. 
 
2. Skills resource 
Identifying, training and fostering a generation of clinically-informed data 
scientists from a wide range of backgrounds must be a top priority. This requires 
multidisciplinary training programmes, which expose scientists, informaticians 
and statisticians to commonly used clinical data, diagnoses and treatments, as 
well as a range of relevant methodological approaches. Data scientists will 
usually need further postgraduate training in statistics and computational 
methods. Trainees will need to be familiar with ethical and regulatory 
requirements as well as prepared to become familiar with the diverse ways in 
which health data are recorded and stored. Given the diversity of resources and 
methodologies, a variety of approaches seems inevitable. Particular care and 
attention to the career structure of data scientists will be needed to nurture 
early-career researchers and ensure that expensively acquired expertise is not 
lost after training. A spectrum of skills and disciplines needs to be present in a 
data science team and its leadership as well as a common understanding of the 
need for complementary expertise. As data science evolves in fields such as 
engineering and finance, there will be opportunities to learn from their 
experience. 
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3. National and international collaboration 
In order to achieve maximum reach and impact, there is a need to develop and 
maintain international and interdisciplinary databases and the networks to 
support their efficient use. There are many examples of this process working 
well in areas such as genomics53 and brain imaging54, where international 
consortia have brought together databases of unparalleled size and scope. There 
are particular challenges in expanding these initiatives to low and middle-income 
countries where the infrastructure may be more limited and low cost methods of 
data collection and storage will be needed. Clinical information from paid and 
public health providers may also come with differing governance frameworks 
and commercial interests, but overcoming these barriers will prove beneficial for 
all parties.  
 
There is also much work to be done in standardising assessments, outcome 
measures and terminology within, let alone between, nations. UK and 
international research charities such as MQ, the Wellcome Trust and publicly 
funded research councils have an important role to play in matching researchers 
and their research questions to datasets spanning multiple subject domains and 
countries. Routine health record data with detailed mental health coverage are 
stored in parts of the UK, Australia as well as the exemplary Scandinavian 
systems. Some projects, like UK Biobank, encourage external data analysis even 
as data are being collected, whereas others will not be openly shared until the 
original funder-approved aims have been met. Subject to regulatory approvals, 
it is desirable that systems should be put in place to facilitate the incorporation 
of data from time-limited projects as soon as practicable. Intellectual property 
and resource considerations may make this challenging. Fostering 
collaborations, developing safe havens to facilitate joint working and convening 
advisory groups with wide representation will help enhance complementarity 
across projects and data collections. 
 
OUR VISION OF THE FUTURE 
Against a backdrop of no fundamentally new pharmacologic treatment in the 
past 60 years and a progressive pharmaceutical industry withdrawal from mental 
health Research and Development, an alternative course is essential. Mental 
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health remains the leading area of unmet medical need in the developed world, 
and is rapidly acquiring the same status in the developing world.  
 
Combining large healthcare and administrative datasets with real-time 
monitoring, laboratory, genomic and imaging data could achieve a step change 
in the way healthcare is provided and research is organised. In our opinion, data 
science will greatly enhance our ability to conduct discovery science, 
epidemiological studies, personalised medicine and plan services. Without the 
better understanding of mental health problems that will come with use of Big 
Data, longer term visions for self-management, better treatments and learning 
health systems will not be possible. It is thus vital that current initiatives in data 
science recognise and support this need.  
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Legend to Figure 1 What is data science: 
Figure showing the components of data science.  
 
Legend to Figure 2: The ‘Scottish’ Model 
Figure shows the linkable data sources available in Scotland, whose 
linkage is facilitated by the unique CHI number. Administrative data is 
shown separately from NHS data in the lower panel.  
 
 
 
 
  
 17 
References 
1. Dhar V. Data Science and Prediction. Commun Acm 2013; 56(12): 64-73. 
 
2. Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease 
attributable to mental and substance use disorders: findings from the Global 
Burden of Disease Study 2010. Lancet 2013; 382(9904): 1575-86. 
 
3. Barr B, Kinderman P, Whitehead M. Trends in mental health inequalities 
in England during a period of recession, austerity and welfare reform 2004 to 
2013. Soc Sci Med 2015; 147: 324-31. 
 
4. van Heuvelen MJG, Hochstenbach JBM, Brouwer WH, et al. Differences 
between participants and non-participants in an RCT on physical activity and 
psychological interventions for older persons. Aging Clinical and Experimental 
Research 2005; 17(3): 236-45. 
 
5. Rogers A, Harris T, Victor C, et al. Which older people decline 
participation in a primary care trial of physical activity and why: insights from a 
mixed methods approach. BMC Geriatr 2014; 14. 
 
6. Goldberg M, Chastang JF, Zins M, Niedhammer I, Leclerc A. Health 
problems were the strongest predictors of attrition during follow-up of the 
GAZEL cohort. Journal of clinical epidemiology 2006; 59(11): 1213-21. 
 
7. Torous J, Baker JT. Why Psychiatry Needs Data Science and Data Science 
Needs Psychiatry: Connecting With Technology. JAMA Psychiatry 2016; 73(1): 3-
4. 
 
8. Smith DJ, Nicholl BI, Cullen B, et al. Prevalence and characteristics of 
probable major depression and bipolar disorder within UK biobank: cross-
sectional study of 172,751 participants. PLoS One 2013; 8(11): e75362. 
 
9. Smith BH, Campbell A, Linksted P, et al. Cohort profile: Generation 
Scotland: Scottish Family Health Study (GS:SFHS). The study, its participants and 
their potential for genetic research on health and illness. International journal of 
epidemiology 2012. 
 
10. Smith BH, Campbell H, Blackwood D, et al. Generation Scotland: the 
Scottish Family Health Study; a new resource for researching genes and 
heritability. BMC Med Genet 2006; 7: 74. 
 
11. Fraser A, Macdonald-Wallis C, Tilling K, et al. Cohort Profile: the Avon 
Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int J 
Epidemiol 2013; 42(1): 97-110. 
 
12. Ford DV, Jones KH, Verplancke JP, et al. The SAIL Databank: building a 
national architecture for e-health research and evaluation. BMC Health Serv Res 
2009; 9: 157. 
 
 18 
13. Lyons RA, Jones KH, John G, et al. The SAIL databank: linking multiple 
health and social care datasets. BMC medical informatics and decision making 
2009; 9: 3. 
 
14. Lloyd K, McGregor J, John A, et al. A national population-based e-cohort of 
people with psychosis (PsyCymru) linking prospectively ascertained 
phenotypically rich and genetic data to routinely collected records: overview, 
recruitment and linkage. Schizophrenia research 2015; 166(1-3): 131-6. 
 
15. Department of Health. Personalised health and care 2020: Using data and 
Technology to Transform Outcomes for Patients and Citizens. London: HM 
Givernment, 2014. 
 
16. Clarke A, Adamson J, Sheard L, Cairns P, Watt I, Wright J. Implementing 
electronic patient record systems (EPRs) into England's acute, mental health and 
community care trusts: a mixed methods study. BMC medical informatics and 
decision making 2015; 15: 85. 
 
17. Coorevits P, Sundgren M, Klein GO, et al. Electronic health records: new 
opportunities for clinical research. J Intern Med 2013; 274(6): 547-60. 
 
18. Jensen PB, Jensen LJ, Brunak S. Mining electronic health records: towards 
better research applications and clinical care. Nature reviews Genetics 2012; 
13(6): 395-405. 
 
19. Nuffield Council on Bioethics. The collection, linking and use of data in 
biomedical research and health care: ethical issues, 2015. 
 
20. Morrison Z, Fernando B, Kalra D, Cresswell K, Sheikh A. National 
evaluation of the benefits and risks of greater structuring and coding of the 
electronic health record: exploratory qualitative investigation. J Am Med Inform 
Assoc 2014; 21(3): 492-500. 
 
21. Delaney BC, Peterson KA, Speedie S, Taweel A, Arvanitis TN, Hobbs FD. 
Envisioning a learning health care system: the electronic primary care research 
network, a case study. Ann Fam Med 2012; 10(1): 54-9. 
 
22. Bernat JL. Ethical and quality pitfalls in electronic health records. 
Neurology 2013; 81(17): 1558. 
 
23. Whooley O. Diagnostic ambivalence: psychiatric workarounds and the 
Diagnostic and Statistical Manual of Mental Disorders. Sociol Health Illn 2010; 
32(3): 452-69. 
 
24. Weiskopf NG, Weng C. Methods and dimensions of electronic health 
record data quality assessment: enabling reuse for clinical research. J Am Med 
Inform Assoc 2013; 20(1): 144-51. 
 
 19 
25. Denny JC. Chapter 13: Mining electronic health records in the genomics 
era. PLoS computational biology 2012; 8(12): e1002823. 
 
26. Sinha S, Peach G, Poloniecki JD, Thompson MM, Holt PJ. Studies using 
English administrative data (Hospital Episode Statistics) to assess health-care 
outcomes-systematic review and recommendations for reporting. European 
journal of public health 2013; 23(1): 86-92. 
 
27. Health & Social Care Information Centre. Users and Uses of Hospital 
Episode Statistics, 2012. 
 
28. Heath & Social Care Information Centre. Supporting open data and 
transparency, 2015. 
 
29. RSA Open Public Services Network. Exploring how available NHS data can 
be used to show the inequality gap in mental healthcare, 2015. 
 
30. CAPITA. The quality of clinical coding in the NHS, 2014. 
 
31. Perera G, Broadbent M, Callard F, et al. Cohort profile of the South London 
and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) 
Case Register: current status and recent enhancement of an Electronic Mental 
Health Record-derived data resource. BMJ open 2016; 6(3): e008721. 
 
32. Stewart R, Soremekun M, Perera G, et al. The South London and Maudsley 
NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: 
development and descriptive data. BMC Psychiatry 2009; 9: 51. 
 
33. Fernandes AC, Cloete D, Broadbent MT, et al. Development and evaluation 
of a de-identification procedure for a case register sourced from mental health 
electronic records. BMC medical informatics and decision making 2013; 13: 71. 
 
34. Su YP, Chang CK, Hayes RD, et al. Retrospective chart review on exposure 
to psychotropic medications associated with neuroleptic malignant syndrome. 
Acta Psychiatr Scand 2014; 130(1): 52-60. 
 
35. Oram S, Khondoker M, Abas M, Broadbent M, Howard LM. Characteristics 
of trafficked adults and children with severe mental illness: a historical cohort 
study. Lancet Psychiatry 2015; 2(12): 1084-91. 
 
36. Chang CK, Hayes RD, Perera G, et al. Life expectancy at birth for people 
with serious mental illness and other major disorders from a secondary mental 
health care case register in London. PLoS One 2011; 6(5): e19590. 
 
37. Chang CK, Hayes RD, Broadbent MT, et al. A cohort study on mental 
disorders, stage of cancer at diagnosis and subsequent survival. BMJ open 2014; 
4(1): e004295. 
 
 20 
38. Patel R, Jayatilleke N, Broadbent M, et al. Negative symptoms in 
schizophrenia: a study in a large clinical sample of patients using a novel 
automated method. BMJ open 2015; 5(9): e007619. 
 
39. Patel R, Lloyd T, Jackson R, et al. Mood instability is a common feature of 
mental health disorders and is associated with poor clinical outcomes. BMJ open 
2015; 5(5): e007504. 
 
40. Perera G, Khondoker M, Broadbent M, Breen G, Stewart R. Factors 
associated with response to acetylcholinesterase inhibition in dementia: a cohort 
study from a secondary mental health care case register in london. PLoS One 
2014; 9(11): e109484. 
 
41. Kadra G, Stewart R, Shetty H, et al. Extracting antipsychotic polypharmacy 
data from electronic health records: developing and evaluating a novel process. 
BMC Psychiatry 2015; 15: 166. 
 
42. Hayes RD, Downs J, Chang CK, et al. The effect of clozapine on premature 
mortality: an assessment of clinical monitoring and other potential confounders. 
Schizophr Bull 2015; 41(3): 644-55. 
 
43. Fleming I, Jones M, Bradley J, Wolpert M. Learning from a Learning 
Collaboration: The CORC Approach to Combining Research, Evaluation and 
Practice in Child Mental Health. Administration and Policy in Mental Health and 
Mental Health Services Research 2014; 43(3): 297-301. 
 
44. Wellcome Trust. Qualitative Research into Public Attitudes to Personal 
Data and Linking Personal Data, 2013. 
 
45. Taylor MJ, Taylor N. Health research access to personal confidential data 
in England and Wales: assessing any gap in public attitude between preferable 
and acceptable models of consent. Life Sci Soc Policy 2014; 10: 15. 
 
46. Ridgeway JL, Han LC, Olson JE, et al. Potential Bias in the Bank: What 
Distinguishes Refusers, Nonresponders and Participants in a Clinic-Based 
Biobank? Public Health Genomics 2013; 16(3): 118-26. 
 
47. Papoulias C, Robotham D, Drake G, Rose D, Wykes T. Staff and service 
users' views on a 'Consent for Contact' research register within psychosis 
services: a qualitative study. Bmc Psychiatry 2014; 14. 
 
48. Callard F, Broadbent M, Denis M, et al. Developing a new model for patient 
recruitment in mental health services: a cohort study using Electronic Health 
Records. BMJ open 2014; 4(12). 
 
49. Williams H, Spencer K, Sanders C, et al. Dynamic Consent: A Possible 
Solution to Improve Patient Confidence and Trust in How Electronic Patient 
Records Are Used in Medical Research. Jmir Med Inf 2015; 3(1). 
 
 21 
50. Willison DJ, Steeves V, Charles C, et al. Consent for use of personal 
information for health research: Do people with potentially stigmatizing health 
conditions and the general public differ in their opinions? Bmc Med Ethics 2009; 
10. 
 
51. Pavis S, Morris AD. Unleashing the power of administrative health data: 
the Scottish model. Public Health Res Pr 2015; 25(4). 
 
52. Martin DJ, Park J, Langan J, Connolly M, Smith DJ, Taylor M. Socioeconomic 
status and prescribing for schizophrenia: analysis of 3200 cases from the 
Glasgow Psychosis Clinical Information System (PsyCIS). Psychiatr Bull (2014) 
2014; 38(2): 54-7. 
 
53. O'Donovan MC. What have we learned from the Psychiatric Genomics 
Consortium. World Psychiatry 2015; 14(3): 291-3. 
 
54. Thompson PM, Stein JL, Medland SE, et al. The ENIGMA Consortium: 
large-scale collaborative analyses of neuroimaging and genetic data. Brain 
Imaging Behav 2014; 8(2): 153-82. 
 
 
